Corporate digest

HC Surgical Specialists

HC SURGICAL Specialists has signed an exclusive three-year agreement to provide consultancy and medical services for The Prestige Hospital in Cambodia, marking its foray into the South-east Asian country.

This will create an additional revenue stream for the group, and is aligned with its long-term plans for regional expansion, HC Surgical said in its bourse filing.

The three-year period for the exclusive agreement will start when the new endoscopy centre is operational, which is estimated to be on March 1.

The deal is not expected to have a material impact on the consolidated earnings per share or net tangible assets per share of the group for the current financial year ending May 31, 2020.

Miyoshi

MANUFACTURER Miyoshi on Tuesday posted a net loss of S$314,000 for its first quarter ended Nov 30, compared to a net profit of S$4.3 million a year ago.

Revenue dipped 3.5 per cent to S$14 million from S$14.5 million a year ago, mainly due to lower sales orders from the data storage and automotive segments in China and the Philippines. Loss per share was 0.01 cent, a reversal from earnings per share of 0.71 cent a year ago.

The bottom line fell because of the absence of a one-off gain on disposal of its Singapore industrial property at 5 Second Chin Bee Road, as well as a share of loss from associate of about S$367,000, which reflects the share of results of loss-making Chinese electric vehicle company Core Power, which Miyoshi has invested in.

The Trendlines Group

THE STARTUP incubator said one of its portfolio companies is in negotiations for the sale of all its shares to an unnamed public corporation. The portfolio company has signed a non-binding letter of intent with the potential buyer, which has "demanded confidentiality" regarding the negotiations, according to Catalist-listed Trendlines' regulatory update.

If a deal is inked and the startup's share sale is completed, the transaction is expected to have a material positive impact on Trendlines' net tangible assets per share and earnings per share for the fiscal year ended Dec 31, 2019, and/or ending Dec 31, 2020.